{"gene":"COL3A1","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":1988,"finding":"A multi-exon deletion in one COL3A1 allele (3.3 kb deletion in the triple-helical coding domain) produces type III procollagen with decreased thermal stability, reduced secretion efficiency, and impaired processing, establishing that structural integrity of the triple helix is required for normal folding, secretion, and protease processing of type III collagen.","method":"Fibroblast culture biochemical analysis, mRNA/protein analysis, thermal stability assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical characterization with multiple orthogonal methods (thermal stability, secretion assay, protein analysis) in a focused single-gene study; foundational characterization","pmids":["2834369"],"is_preprint":false},{"year":1990,"finding":"A glycine-to-arginine substitution (G619R) in the triple-helical domain of COL3A1 decreases the thermal unfolding temperature of type III procollagen in cultured skin fibroblasts, demonstrating that glycine substitutions in the triple helix destabilize the collagen molecule and cause familial aortic aneurysms.","method":"Cultured skin fibroblast analysis, thermal unfolding assay, DNA sequencing","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical measurement (thermal stability) of mutant protein from patient fibroblasts, replicated across multiple family members","pmids":["2243125"],"is_preprint":false},{"year":1990,"finding":"Identical G+1 splice-site mutations in three different introns of COL3A1 produce distinct patterns of aberrant RNA splicing (exon skipping, cryptic splice site use, or intron retention), demonstrating that context of adjacent introns—not the mutation per se—determines the splicing outcome.","method":"RNA analysis, cDNA sequencing, splice-site analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct comparative molecular analysis of three independent mutations in the same gene with orthogonal RNA/DNA methods","pmids":["2365710"],"is_preprint":false},{"year":1990,"finding":"A splice-site mutation (G+1 IVS20 → A) in COL3A1 causes aberrant RNA splicing producing structurally abnormal type III procollagen; the resulting protein has impaired secretion and function, leading to vascular rupture phenotype.","method":"RNA splicing analysis, fibroblast protein studies, DNA sequencing","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — molecular characterization with RNA and protein analysis in patient fibroblasts, single lab","pmids":["2349939"],"is_preprint":false},{"year":1990,"finding":"A splice-site mutation (G-to-A at the GT dinucleotide of intron 41 donor site) in COL3A1 causes exon 41 skipping, producing a type III procollagen molecule lacking the collagenase cleavage site (Gly781-Ile782) and the cyanogen bromide site (Met797), making it resistant to both collagenase and CNBr digestion; secretion is markedly reduced and thermal stability is decreased.","method":"cDNA sequencing, CNBr peptide mapping, chemical cleavage heteroduplex analysis, protein secretion assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods (CNBr mapping, collagenase resistance, secretion assay, sequencing) in a single rigorous study establishing mechanism","pmids":["2145268"],"is_preprint":false},{"year":1992,"finding":"Glycine-to-aspartate substitution at position 1018 in the COL3A1 triple helix markedly decreases secretion of type III procollagen by cultured fibroblasts, demonstrating that glycine substitutions near the C-terminus of the helix strongly impair secretion.","method":"Cultured skin fibroblast protein analysis, PCR/sequencing, quantification of secreted collagen","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct measurement of secreted protein from patient fibroblasts, single lab","pmids":["1496983"],"is_preprint":false},{"year":1993,"finding":"Glycine-to-glutamic-acid substitution at position 1021 (the most C-terminal glycine mutation characterized at the time) in COL3A1 causes poor secretion of type III procollagen, slower electrophoretic migration (indicating overmodification), and partial instability to trypsin digestion at 25°C, linking C-terminal helix mutations to specific biochemical defects.","method":"Fibroblast protein analysis, SDS-PAGE, trypsin sensitivity assay","journal":"American journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical assays on patient fibroblasts, single lab","pmids":["8098182"],"is_preprint":false},{"year":1997,"finding":"Mutations in COL3A1 (point mutations substituting glycine residues near the C-terminus, and exon-skipping mutations) cause ultrastructurally abnormal collagen fibrils in dermis (reduced fibril diameter to 65–80 nm vs. 95–110 nm in normal), dilated rough endoplasmic reticulum, and reduced dermal collagen content; severity of structural changes correlates with position and nature of the mutation.","method":"Light microscopy, transmission and scanning electron microscopy of skin biopsies from 22 genotyped EDS IV patients","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic ultrastructural analysis across 22 patients with defined mutations, multiple orthogonal microscopy methods","pmids":["9036918"],"is_preprint":false},{"year":2001,"finding":"Frameshift and nonsense mutations in COL3A1 leading to premature termination codons cause nonsense-mediated mRNA decay (NMD), resulting in haploinsufficiency for type III procollagen rather than production of structurally abnormal protein; a C-terminal truncation mutation (Arg1432Ter) in the final exon escapes NMD but produces a truncated protein not incorporated into mature type III procollagen trimers.","method":"RT-PCR, mRNA stability assay, protein analysis of fibroblast culture media","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic dissection of NMD pathway using multiple patient mutations and orthogonal RNA/protein methods","pmids":["11577371"],"is_preprint":false},{"year":2004,"finding":"Fibroblasts from EDS IV patients with COL3A1 mutations fail to organize type III collagen and fibronectin into extracellular matrix, downregulate α2β1 integrin, and recruit αvβ3 instead of α5β1 integrin; treatment with exogenous purified type III collagen restores normal integrin distribution and ECM organization, demonstrating that type III collagen controls α2β1 integrin function which in turn regulates fibronectin receptor recruitment.","method":"Immunofluorescence, western blot, treatment with purified collagen and function-blocking antibodies, ECM organization assays in patient fibroblasts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal experiments including rescue with purified protein and function-blocking antibodies establishing mechanistic link between COL3A1 and integrin regulation","pmids":["14970208"],"is_preprint":false},{"year":2012,"finding":"Loss of Col3a1 in mice causes breakdown of the pial basement membrane starting at E11.5 with consequent neuronal overmigration, cobblestone-like cortical malformation, and marginal zone heterotopias, establishing type III collagen as a structural ligand required for pial basement membrane integrity during cortical development; α-dystroglycan expression and modification were unaffected in Col3a1-null meningeal fibroblasts.","method":"Histological analysis, immunofluorescence, Col3a1 knockout mouse model, time-course developmental analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with defined cellular phenotype, time-course analysis, negative control (α-dystroglycan) included","pmids":["22235340"],"is_preprint":false},{"year":2014,"finding":"A missense point mutation in the PIIINP (N-terminal propeptide) segment of Col3a1 is the causative gain-of-function mutation in Tsk2/+ mice; this mutation drives excessive ECM deposition and skin fibrosis, establishing that the N-terminal propeptide domain can confer a fibrotic gain-of-function phenotype distinct from the loss-of-function EDS IV mutations.","method":"Linkage analysis, RNA sequencing, genome capture DNA sequencing, in vivo and in vitro genetic complementation tests","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic complementation in vivo and in vitro with multiple molecular methods proving causality of the specific mutation","pmids":["25330296"],"is_preprint":false},{"year":2017,"finding":"Biallelic (homozygous or compound heterozygous) mutations in COL3A1 are associated with cobblestone-like cortical malformation, white matter changes, and cerebellar cysts similar to the phenotype of GPR56 mutations, establishing that the type III collagen–GPR56 ligand–receptor axis is required for cortical lamination and brain development.","method":"Exome sequencing, functional assays on dermal fibroblasts, MRI brain imaging in multiple families","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and functional fibroblast data across three families, consistent phenotype linking COL3A1 to GPR56 signaling axis","pmids":["28258187"],"is_preprint":false},{"year":2018,"finding":"NEDD9, a SMAD3 docking partner, forms a complex with NKX2-5 transcription factor when SMAD3-NEDD9 interaction is impaired by oxidation of Cys18 (induced by aldosterone); increased NEDD9-NKX2-5 complex binds to the COL3A1 promoter and drives collagen III expression in pulmonary artery endothelial cells, promoting vascular fibrosis in pulmonary arterial hypertension via a TGF-β-independent mechanism.","method":"Microscale thermophoresis (protein-protein interaction), atomic force microscopy (cell stiffness), ChIP (NKX2-5 binding to COL3A1), cell culture, animal models of PAH, immunohistochemistry co-localization","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods including direct binding assay, ChIP, functional rescue, and in vivo validation establishing upstream regulatory mechanism of COL3A1 expression","pmids":["29899023"],"is_preprint":false},{"year":2018,"finding":"Transgenic mice expressing a glycine substitution mutation (p.Gly182Ser) in Col3a1 develop reduced total collagen content, an abnormal collagen III:I ratio, and severely malformed collagen fibrils in dermal and arterial ECM, demonstrating that mutant type III collagen disrupts heterotypic type III:I collagen fibrillogenesis in vivo.","method":"Transgenic mouse model, collagen content assay, electron microscopy of collagen fibrils, ratio analysis","journal":"Matrix biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic mouse with defined glycine substitution, ultrastructural and biochemical analysis of collagen fibrils providing mechanistic link between mutation and fibrillogenesis defect","pmids":["29551664"],"is_preprint":false},{"year":2018,"finding":"Dominant-negative COL3A1 mutations in patient fibroblasts cause aberrant type III collagen (COLLIII) expression that leads to disassembly of ECM structural components (fibrillins, EMILINs, elastin) and reduction of proteoglycans (perlecan, decorin, versican), disruption of ER homeostasis markers (PDI distribution, reduction of FKBP22), and altered cell cycle regulation, as revealed by transcriptome and protein analyses.","method":"Microarray transcriptome analysis, protein analysis (western blot, immunofluorescence), cultured patient fibroblasts","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transcriptome plus protein validation in patient fibroblasts with defined mutations, single lab","pmids":["29346445"],"is_preprint":false},{"year":2023,"finding":"ECM generated from vEDS patient fibroblasts with COL3A1 mutations (including a glycine substitution) shows altered protein composition (upregulation of collagen subtypes and structural proteins), increased glycosaminoglycan content, and unique viscoelastic mechanical properties (increased stress relaxation time constant) compared to healthy donor ECM; this mechanically altered ECM reduces migration speed of seeded human aortic endothelial cells.","method":"Cell-derived ECM synthesis from primary patient fibroblasts, mass spectrometry protein content analysis, glycosaminoglycan quantification, atomic force microscopy and rheology for viscoelastic properties, endothelial cell migration assay","journal":"Acta biomaterialia","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — reconstitution of patient-derived ECM with multiple orthogonal biochemical and biophysical methods plus functional cell assay; single lab","pmids":["37187299"],"is_preprint":false},{"year":2025,"finding":"COL3A1 glycine mutations (G189S and G906R) in patient fibroblasts cause secretion of misfolded collagen III, intracellular collagen retention, ER stress via IRE1 and PERK pathway activation, reduced cell proliferation, and apoptosis; treatment with 4-phenylbutyric acid (PBA) rescues ER stress, improves thermal stability of secreted collagen, reduces apoptosis, and corrects matrix defects, with efficacy influenced by mutation position and allelic heterogeneity.","method":"Primary patient fibroblast cultures, ER stress pathway analysis (IRE1/PERK), thermal stability assay, collagen secretion assay, proliferation assay, apoptosis assay, pharmacological rescue with PBA","journal":"Cell death discovery","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal mechanistic assays in patient-derived cells with pharmacological rescue experiment confirming ER stress as operative mechanism; single lab","pmids":["40280907"],"is_preprint":false},{"year":2024,"finding":"ELAVL1 (HuR) enhances mRNA stability and expression of COL3A1, while YY1 promotes COL3A1 transcription; both mechanisms contribute to COL3A1 upregulation in cisplatin-resistant NSCLC cells, and COL3A1 knockdown reverses ELAVL1- or YY1-depletion-mediated resistance phenotypes.","method":"ChIP assay, luciferase reporter assay, qPCR, western blot, mRNA stability assay, loss-of-function experiments","journal":"Cancer biology & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase confirming direct YY1-COL3A1 transcriptional regulation and ELAVL1 mRNA stabilization; single lab, cancer cell context","pmids":["38530094"],"is_preprint":false},{"year":2015,"finding":"C-propeptide region variants in COL3A1 (exons 49–52) affect the initiation of C-terminal assembly of procollagen monomers in collagen biosynthesis; X-ray crystallographic structural data combined with clinical phenotyping inform pathogenicity classification of missense variants in this domain.","method":"X-ray crystallography of C-propeptide region variants, clinical phenotyping, biochemical analysis","journal":"American journal of medical genetics. Part A","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — crystal structure data mentioned but abstract provides limited mechanistic detail on experimental outcomes; single study","pmids":["25846194"],"is_preprint":false},{"year":2010,"finding":"Haploinsufficiency of Col3a1 (heterozygous 185 kb deletion including promoter and exons 1–39) causes autosomal-dominant susceptibility to thoracic aortic dissection in mice with aberrant collagen fibrillogenesis in the aortic wall, without elevated blood pressure or aneurysm formation.","method":"Spontaneous mouse mutant identification, molecular genetic analysis, echocardiography, histological analysis","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — defined deletion allele with molecular characterization plus histological and functional cardiovascular phenotyping in vivo","pmids":["21071432"],"is_preprint":false},{"year":2013,"finding":"Angiotensin II infusion in Col3a1 haploinsufficient mice selectively promotes thoracic aortic dissections and ruptures associated with low aortic collagen fibril content, demonstrating that reduced type III collagen renders the aortic wall mechanically vulnerable to hemodynamic stress; the same blood pressure increase produced by norepinephrine does not cause comparable mortality, implicating angiotensin II-specific effects beyond blood pressure.","method":"Angiotensin II infusion model in Col3a1+/- mice, echocardiography, histological analysis, mortality comparison","journal":"Hypertension","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo pharmacological model with defined genetic background and histological endpoint, single lab","pmids":["23630948"],"is_preprint":false}],"current_model":"COL3A1 encodes the pro-α1(III) chain that homotrimerizes to form type III procollagen; glycine substitutions or splice mutations in the triple-helical domain reduce thermal stability, impair secretion, cause ER stress via IRE1/PERK activation, and disrupt heterotypic type I/III collagen fibrillogenesis, while haploinsufficiency reduces ECM collagen content and mechanical integrity of arterial and connective tissue walls; at the cell-biology level, type III collagen acts as an ECM ligand controlling α2β1 integrin function and downstream fibronectin/integrin receptor recruitment, and as the ligand for GPR56 required for pial basement membrane integrity and cortical lamination during brain development; transcriptional regulation involves YY1-driven promoter activity and ELAVL1-mediated mRNA stabilization, and aldosterone-induced oxidation of NEDD9 releases NKX2-5 to drive COL3A1 expression in a TGF-β-independent pathway relevant to pulmonary vascular fibrosis."},"narrative":{"mechanistic_narrative":"COL3A1 encodes the pro-α1(III) chain whose homotrimer forms type III procollagen, an extracellular matrix structural protein essential for the mechanical integrity of arterial and connective tissue walls and for tissue patterning during development [PMID:2834369, PMID:29551664, PMID:21071432]. The structural integrity of the Gly-X-Y triple-helical domain is required for normal folding, secretion, and protease processing: triple-helix deletions and glycine substitutions lower thermal stability and impair secretion [PMID:2834369, PMID:2243125, PMID:1496983], while C-terminal helix mutations and exon-skipping events further compromise secretion and remove protease/CNBr cleavage sites [PMID:2145268, PMID:8098182]. Splice-site mutations generate context-dependent aberrant transcripts (exon skipping, cryptic site use, intron retention) yielding abnormal procollagen [PMID:2365710, PMID:2145268], whereas frameshift and nonsense mutations trigger nonsense-mediated decay and consequent haploinsufficiency [PMID:11577371]. Misfolded mutant chains are retained intracellularly and activate ER stress through the IRE1 and PERK arms, driving reduced proliferation and apoptosis that are reversible by chemical chaperone treatment with 4-phenylbutyric acid [PMID:40280907]. At the tissue level, mutant or reduced type III collagen disrupts heterotypic type III:I collagen fibrillogenesis, lowering collagen content and altering fibril architecture in dermis and aorta [PMID:9036918, PMID:29551664], and haploinsufficiency confers susceptibility to thoracic aortic dissection that is exacerbated by angiotensin II-driven hemodynamic stress [PMID:21071432, PMID:23630948]. Beyond its structural role, type III collagen functions as an ECM ligand: it controls α2β1 integrin function and downstream fibronectin/integrin receptor recruitment [PMID:14970208], and serves as the ligand for GPR56 required for pial basement membrane integrity and cortical lamination, with biallelic loss causing cobblestone-like cortical malformation [PMID:22235340, PMID:28258187]. COL3A1 expression is controlled transcriptionally by YY1 and post-transcriptionally by ELAVL1-mediated mRNA stabilization [PMID:38530094], and by an aldosterone-induced NEDD9–NKX2-5 pathway that drives collagen III expression in pulmonary artery endothelial cells independently of TGF-β [PMID:29899023]. Dominant glycine and splice mutations underlie vascular Ehlers-Danlos syndrome (EDS IV) and familial aortic aneurysm/dissection [PMID:2243125, PMID:9036918].","teleology":[{"year":1988,"claim":"Established that triple-helix structural integrity is a prerequisite for normal folding, secretion, and processing of type III procollagen, defining the molecular logic of dominant COL3A1 disease.","evidence":"Biochemical analysis of a triple-helical domain deletion in patient fibroblasts with thermal stability and secretion assays","pmids":["2834369"],"confidence":"High","gaps":["Did not address how reduced thermal stability translates to tissue-level fragility","Single deletion allele tested"]},{"year":1990,"claim":"Showed that point glycine substitutions in the triple helix destabilize the collagen molecule and cause familial aortic aneurysm, and that splice-site mutations produce context-dependent aberrant transcripts.","evidence":"Thermal unfolding assays on fibroblast-derived mutant procollagen and comparative RNA/cDNA analysis of multiple splice mutations","pmids":["2243125","2365710","2349939","2145268"],"confidence":"High","gaps":["Did not establish in vivo tissue consequences","Splicing outcome rules predictive only for the introns tested"]},{"year":1992,"claim":"Localized secretion sensitivity to the C-terminal region of the helix, showing C-terminal glycine substitutions strongly impair procollagen secretion.","evidence":"Secreted collagen quantification, SDS-PAGE migration and trypsin sensitivity assays in patient fibroblasts","pmids":["1496983","8098182"],"confidence":"Medium","gaps":["Single lab","Mechanistic basis of position-dependent secretion defect not resolved"]},{"year":1997,"claim":"Connected molecular mutation type to ultrastructural matrix pathology, showing reduced fibril diameter, dilated rough ER, and lower dermal collagen content correlating with mutation position.","evidence":"Light, transmission and scanning electron microscopy of skin biopsies from 22 genotyped EDS IV patients","pmids":["9036918"],"confidence":"High","gaps":["Correlation descriptive, not causal","Did not define the signaling consequence of dilated ER"]},{"year":2001,"claim":"Distinguished haploinsufficiency from dominant-negative mechanisms by showing premature termination codons trigger NMD while a final-exon truncation escapes decay but fails to incorporate into trimers.","evidence":"RT-PCR, mRNA stability assays and protein analysis of patient fibroblast media","pmids":["11577371"],"confidence":"High","gaps":["Did not quantify phenotypic difference between haploinsufficient and dominant-negative patients","Limited mutation set"]},{"year":2004,"claim":"Revealed a non-structural signaling role: type III collagen controls α2β1 integrin function and fibronectin receptor recruitment, with rescue by exogenous collagen establishing causality.","evidence":"Immunofluorescence, western blot, function-blocking antibodies and purified-collagen rescue in EDS IV patient fibroblasts","pmids":["14970208"],"confidence":"High","gaps":["Downstream integrin signaling cascade not mapped","Relevance to in vivo vascular phenotype not tested"]},{"year":2010,"claim":"Demonstrated that Col3a1 haploinsufficiency alone causes autosomal-dominant susceptibility to thoracic aortic dissection via aberrant aortic fibrillogenesis, independent of blood pressure or aneurysm.","evidence":"Spontaneous mouse deletion mutant with molecular genetics, echocardiography and histology","pmids":["21071432"],"confidence":"High","gaps":["Did not identify the hemodynamic trigger of dissection","Mechanism of selective thoracic vulnerability unclear"]},{"year":2012,"claim":"Identified type III collagen as a structural ligand required for pial basement membrane integrity, with loss causing neuronal overmigration and cobblestone cortical malformation.","evidence":"Col3a1 knockout mouse with time-course histology and immunofluorescence, including α-dystroglycan negative control","pmids":["22235340"],"confidence":"High","gaps":["Receptor mediating the developmental requirement not identified in this study","Did not test rescue"]},{"year":2013,"claim":"Showed angiotensin II selectively precipitates aortic dissection in haploinsufficient mice beyond its blood-pressure effect, implicating an angiotensin II-specific vulnerability of collagen-poor walls.","evidence":"Angiotensin II versus norepinephrine infusion in Col3a1+/- mice with echocardiography, histology and mortality comparison","pmids":["23630948"],"confidence":"Medium","gaps":["Angiotensin II-specific molecular pathway not defined","Single lab"]},{"year":2014,"claim":"Established that the N-terminal propeptide domain can confer a fibrotic gain-of-function, mechanistically distinct from loss-of-function EDS IV mutations.","evidence":"Linkage, RNA-seq, genome capture sequencing and in vivo/in vitro genetic complementation in Tsk2/+ mice","pmids":["25330296"],"confidence":"High","gaps":["Molecular pathway driving excess ECM deposition not defined","Mouse-specific; human relevance untested"]},{"year":2015,"claim":"Defined a role for the C-propeptide in initiating C-terminal assembly of procollagen monomers and used structural data to inform variant pathogenicity.","evidence":"X-ray crystallography of C-propeptide variants combined with clinical phenotyping","pmids":["25846194"],"confidence":"Medium","gaps":["Limited mechanistic outcome detail reported","Single study"]},{"year":2017,"claim":"Linked biallelic COL3A1 loss to a GPR56-like cortical phenotype, establishing the type III collagen–GPR56 ligand–receptor axis in cortical lamination.","evidence":"Exome sequencing, fibroblast functional assays and brain MRI across multiple families","pmids":["28258187"],"confidence":"Medium","gaps":["Direct collagen III–GPR56 binding not demonstrated here","Three families only"]},{"year":2018,"claim":"Defined upstream and downstream consequences of COL3A1 dysregulation: an aldosterone-driven NEDD9–NKX2-5 pathway drives COL3A1 transcription in pulmonary fibrosis, mutant collagen disrupts heterotypic III:I fibrillogenesis in vivo, and dominant-negative mutations perturb ECM assembly and ER homeostasis.","evidence":"Microscale thermophoresis, ChIP and PAH models; transgenic glycine-substitution mouse with EM; transcriptome plus protein analysis of patient fibroblasts","pmids":["29899023","29551664","29346445"],"confidence":"High","gaps":["NEDD9-NKX2-5 pathway shown in PAH context only","ECM disassembly findings from a single lab"]},{"year":2023,"claim":"Showed that vEDS patient-derived matrix has altered composition and viscoelastic properties that impair endothelial cell migration, linking the mutation to mechanical and functional ECM defects.","evidence":"Cell-derived ECM, mass spectrometry, GAG quantification, AFM/rheology and endothelial migration assay","pmids":["37187299"],"confidence":"High","gaps":["Single lab","In vitro ECM may not reflect arterial wall mechanics"]},{"year":2024,"claim":"Identified transcriptional (YY1) and post-transcriptional (ELAVL1) regulators of COL3A1 and implicated COL3A1 in cisplatin resistance in NSCLC.","evidence":"ChIP, luciferase reporter, mRNA stability and loss-of-function assays in NSCLC cells","pmids":["38530094"],"confidence":"Medium","gaps":["Cancer-cell context; relevance to connective tissue regulation unknown","Single lab"]},{"year":2025,"claim":"Established ER stress via IRE1/PERK as an operative pathomechanism of glycine mutations and demonstrated pharmacological rescue with the chemical chaperone 4-phenylbutyric acid.","evidence":"ER stress pathway, thermal stability, secretion, proliferation and apoptosis assays with PBA rescue in patient fibroblasts","pmids":["40280907"],"confidence":"High","gaps":["Rescue efficacy mutation-position dependent","In vivo therapeutic validation absent"]},{"year":null,"claim":"How the structural, integrin-signaling, GPR56-developmental, and ER-stress functions of type III collagen are integrated to produce tissue-specific disease, and whether ER-stress or transcriptional modulation can be therapeutically exploited in vivo, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No in vivo therapeutic proof for PBA or pathway modulation","Mechanistic link between matrix mechanics and clinical vascular events incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,14,20]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[9,10,12]}],"localization":[{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[9,14,16]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7,17]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,5]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[9,14,16]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[17]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[10,12]}],"complexes":[],"partners":["ITGA2","GPR56","FN1","NKX2-5","NEDD9","YY1","ELAVL1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P02461","full_name":"Collagen alpha-1(III) chain","aliases":[],"length_aa":1466,"mass_kda":138.6,"function":"Collagen type III occurs in most soft connective tissues along with type I collagen. Involved in regulation of cortical development. Is the major ligand of ADGRG1 in the developing brain and binding to ADGRG1 inhibits neuronal migration and activates the RhoA pathway by coupling ADGRG1 to GNA13 and possibly GNA12","subcellular_location":"Secreted, extracellular space, extracellular matrix","url":"https://www.uniprot.org/uniprotkb/P02461/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/COL3A1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/COL3A1","total_profiled":1310},"omim":[{"mim_id":"619269","title":"ODONTOCHONDRODYSPLASIA 2 WITH HEARING LOSS AND DIABETES; ODCD2","url":"https://www.omim.org/entry/619269"},{"mim_id":"618343","title":"POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV","url":"https://www.omim.org/entry/618343"},{"mim_id":"612586","title":"ANEURYSM, INTRACRANIAL BERRY, 9; ANIB9","url":"https://www.omim.org/entry/612586"},{"mim_id":"612313","title":"GLASS SYNDROME; GLASS","url":"https://www.omim.org/entry/612313"},{"mim_id":"612280","title":"FUCOSIDASE, ALPHA-L, 1; FUCA1","url":"https://www.omim.org/entry/612280"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Endoplasmic reticulum","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"cervix","ntpm":2222.3},{"tissue":"gallbladder","ntpm":1957.3},{"tissue":"placenta","ntpm":1861.3},{"tissue":"smooth muscle","ntpm":1998.4}],"url":"https://www.proteinatlas.org/search/COL3A1"},"hgnc":{"alias_symbol":[],"prev_symbol":["EDS4A"]},"alphafold":{"accession":"P02461","domains":[{"cath_id":"3.30.750.130","chopping":"1243-1297","consensus_level":"medium","plddt":95.9898,"start":1243,"end":1297},{"cath_id":"2.60.120.1000","chopping":"1301-1466","consensus_level":"high","plddt":96.4408,"start":1301,"end":1466}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P02461","model_url":"https://alphafold.ebi.ac.uk/files/AF-P02461-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P02461-F1-predicted_aligned_error_v6.png","plddt_mean":53.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=COL3A1","jax_strain_url":"https://www.jax.org/strain/search?query=COL3A1"},"sequence":{"accession":"P02461","fasta_url":"https://rest.uniprot.org/uniprotkb/P02461.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P02461/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P02461"}},"corpus_meta":[{"pmid":"31075413","id":"PMC_31075413","title":"Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31075413","citation_count":299,"is_preprint":false},{"pmid":"25758994","id":"PMC_25758994","title":"The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome.","date":"2015","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/25758994","citation_count":182,"is_preprint":false},{"pmid":"2243125","id":"PMC_2243125","title":"A mutation in the gene for type III procollagen (COL3A1) in a family with aortic aneurysms.","date":"1990","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/2243125","citation_count":167,"is_preprint":false},{"pmid":"2834369","id":"PMC_2834369","title":"Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2834369","citation_count":161,"is_preprint":false},{"pmid":"11577371","id":"PMC_11577371","title":"Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11577371","citation_count":144,"is_preprint":false},{"pmid":"29899023","id":"PMC_29899023","title":"NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension.","date":"2018","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29899023","citation_count":118,"is_preprint":false},{"pmid":"8255472","id":"PMC_8255472","title":"Exclusion of mutations in the gene for type III collagen (COL3A1) as a common cause of intracranial aneurysms or cervical artery dissections: results from sequence analysis of the coding sequences of type III collagen from 55 unrelated patients.","date":"1993","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/8255472","citation_count":118,"is_preprint":false},{"pmid":"32766145","id":"PMC_32766145","title":"Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32766145","citation_count":117,"is_preprint":false},{"pmid":"21637106","id":"PMC_21637106","title":"COL3A1 haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy.","date":"2011","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21637106","citation_count":104,"is_preprint":false},{"pmid":"14970208","id":"PMC_14970208","title":"Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate alpha2beta1 integrin, and recruit alphavbeta3 Instead of alpha5beta1 integrin.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14970208","citation_count":96,"is_preprint":false},{"pmid":"2349939","id":"PMC_2349939","title":"Inheritance of an RNA splicing mutation (G+ 1 IVS20) in the type III procollagen gene (COL3A1) in a family having aortic aneurysms and easy bruisability: phenotypic overlap between familial arterial aneurysms and Ehlers-Danlos syndrome type IV.","date":"1990","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2349939","citation_count":92,"is_preprint":false},{"pmid":"25193015","id":"PMC_25193015","title":"Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.","date":"2014","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25193015","citation_count":91,"is_preprint":false},{"pmid":"2365710","id":"PMC_2365710","title":"Identical G+1 to A mutations in three different introns of the type III procollagen gene (COL3A1) produce different patterns of RNA splicing in three variants of Ehlers-Danlos syndrome. IV. An explanation for exon skipping some mutations and not others.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2365710","citation_count":84,"is_preprint":false},{"pmid":"9036918","id":"PMC_9036918","title":"Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis.","date":"1997","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/9036918","citation_count":81,"is_preprint":false},{"pmid":"2875936","id":"PMC_2875936","title":"Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen.","date":"1986","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2875936","citation_count":79,"is_preprint":false},{"pmid":"1981051","id":"PMC_1981051","title":"Mapping of Col3a1 and Col6a3 to proximal murine chromosome 1 identifies conserved linkage of structural protein genes between murine chromosome 1 and human chromosome 2q.","date":"1990","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1981051","citation_count":78,"is_preprint":false},{"pmid":"8881656","id":"PMC_8881656","title":"COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture.","date":"1996","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/8881656","citation_count":75,"is_preprint":false},{"pmid":"30518744","id":"PMC_30518744","title":"miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma.","date":"2018","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/30518744","citation_count":69,"is_preprint":false},{"pmid":"2145268","id":"PMC_2145268","title":"A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2145268","citation_count":64,"is_preprint":false},{"pmid":"29091295","id":"PMC_29091295","title":"MicroRNA-29b-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting COL1A1 and COL3A1.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29091295","citation_count":63,"is_preprint":false},{"pmid":"29551664","id":"PMC_29551664","title":"Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.","date":"2018","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29551664","citation_count":60,"is_preprint":false},{"pmid":"9399899","id":"PMC_9399899","title":"Splicing defects in the COL3A1 gene: marked preference for 5' (donor) spice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV.","date":"1997","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9399899","citation_count":59,"is_preprint":false},{"pmid":"21071432","id":"PMC_21071432","title":"Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome.","date":"2010","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/21071432","citation_count":57,"is_preprint":false},{"pmid":"2777083","id":"PMC_2777083","title":"Cloning and analysis of the 5' portion of the human type-III procollagen gene (COL3A1).","date":"1989","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/2777083","citation_count":56,"is_preprint":false},{"pmid":"24700772","id":"PMC_24700772","title":"Identification of COL3A1 and RAB2A as novel translocation partner genes of PLAG1 in lipoblastoma.","date":"2014","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24700772","citation_count":53,"is_preprint":false},{"pmid":"1496983","id":"PMC_1496983","title":"Substitution of aspartate for glycine 1018 in the type III procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is present in most blood leukocytes of the asymptomatic and mosaic mother.","date":"1992","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1496983","citation_count":48,"is_preprint":false},{"pmid":"1998337","id":"PMC_1998337","title":"Characterization of a large deletion associated with a polymorphic block of repeated dinucleotides in the type III procollagen gene (COL3A1) of a patient with Ehlers-Danlos syndrome type IV.","date":"1991","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1998337","citation_count":47,"is_preprint":false},{"pmid":"2930668","id":"PMC_2930668","title":"Genetic evidence that mutations in the COL1A1, COL1A2, COL3A1, or COL5A2 collagen genes are not responsible for mitral valve prolapse.","date":"1989","source":"British heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/2930668","citation_count":47,"is_preprint":false},{"pmid":"3162228","id":"PMC_3162228","title":"Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to atypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian pedigree.","date":"1988","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/3162228","citation_count":46,"is_preprint":false},{"pmid":"8317500","id":"PMC_8317500","title":"Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring.","date":"1993","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8317500","citation_count":43,"is_preprint":false},{"pmid":"19444361","id":"PMC_19444361","title":"COL3A1 2209G>A is a predictor of pelvic organ prolapse.","date":"2009","source":"International urogynecology journal and pelvic floor dysfunction","url":"https://pubmed.ncbi.nlm.nih.gov/19444361","citation_count":42,"is_preprint":false},{"pmid":"34512730","id":"PMC_34512730","title":"COL3A1 and MMP9 Serve as Potential Diagnostic Biomarkers of Osteoarthritis and Are Associated With Immune Cell Infiltration.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34512730","citation_count":41,"is_preprint":false},{"pmid":"22235340","id":"PMC_22235340","title":"Loss of Col3a1, the gene for Ehlers-Danlos syndrome type IV, results in neocortical dyslamination.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22235340","citation_count":38,"is_preprint":false},{"pmid":"19455184","id":"PMC_19455184","title":"Homozygosity for a null allele of COL3A1 results in recessive Ehlers-Danlos syndrome.","date":"2009","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/19455184","citation_count":37,"is_preprint":false},{"pmid":"29346445","id":"PMC_29346445","title":"Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29346445","citation_count":36,"is_preprint":false},{"pmid":"1352273","id":"PMC_1352273","title":"A single base mutation in the gene for type III collagen (COL3A1) converts glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type IV. An unaffected family member is mosaic for the mutation.","date":"1992","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1352273","citation_count":35,"is_preprint":false},{"pmid":"33819468","id":"PMC_33819468","title":"miR-29a-3p-dependent COL3A1 and COL5A1 expression reduction assists sulforaphane to inhibit gastric cancer progression.","date":"2021","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33819468","citation_count":34,"is_preprint":false},{"pmid":"31694982","id":"PMC_31694982","title":"Long noncoding RNA DNM3OS promotes prostate stromal cells transformation via the miR-29a/29b/COL3A1 and miR-361/TGFβ1 axes.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31694982","citation_count":34,"is_preprint":false},{"pmid":"1684560","id":"PMC_1684560","title":"Exclusion of COL1A1, COL1A2, and COL3A1 genes as candidate genes for Ehlers-Danlos syndrome type I in one large family.","date":"1991","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1684560","citation_count":32,"is_preprint":false},{"pmid":"12140670","id":"PMC_12140670","title":"Analysis of the COL3A1 gene in patients with spontaneous cervical artery dissections.","date":"2002","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12140670","citation_count":31,"is_preprint":false},{"pmid":"20648054","id":"PMC_20648054","title":"Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency.","date":"2010","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/20648054","citation_count":31,"is_preprint":false},{"pmid":"28258187","id":"PMC_28258187","title":"Bi-allelic variants in COL3A1 encoding the ligand to GPR56 are associated with cobblestone-like cortical malformation, white matter changes and cerebellar cysts.","date":"2017","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28258187","citation_count":31,"is_preprint":false},{"pmid":"7665911","id":"PMC_7665911","title":"Ehlers-Danlos syndrome type IV: a single base substitution of the last nucleotide of exon 34 in COL3A1 leads to exon skipping.","date":"1995","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/7665911","citation_count":31,"is_preprint":false},{"pmid":"1370809","id":"PMC_1370809","title":"A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV.","date":"1992","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1370809","citation_count":30,"is_preprint":false},{"pmid":"15193836","id":"PMC_15193836","title":"Association between COL3A1 collagen gene exon 31 polymorphism and risk of floppy mitral valve/mitral valve prolapse.","date":"2004","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/15193836","citation_count":29,"is_preprint":false},{"pmid":"8098182","id":"PMC_8098182","title":"Single base mutation that substitutes glutamic acid for glycine 1021 in the COL3A1 gene and causes Ehlers-Danlos syndrome type IV.","date":"1993","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8098182","citation_count":29,"is_preprint":false},{"pmid":"23630948","id":"PMC_23630948","title":"Angiotensin II promotes thoracic aortic dissections and ruptures in Col3a1 haploinsufficient mice.","date":"2013","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/23630948","citation_count":28,"is_preprint":false},{"pmid":"21086191","id":"PMC_21086191","title":"Traumatic subarachnoid hemorrhage and the COL3A1 gene: emergence of a potential causal link.","date":"2010","source":"Forensic science, medicine, and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21086191","citation_count":28,"is_preprint":false},{"pmid":"26060338","id":"PMC_26060338","title":"Overrepresentation of the COL3A1 AA genotype in Polish skiers with anterior cruciate ligament injury.","date":"2015","source":"Biology of sport","url":"https://pubmed.ncbi.nlm.nih.gov/26060338","citation_count":28,"is_preprint":false},{"pmid":"3224983","id":"PMC_3224983","title":"Genetic distance of two fibrillar collagen loci, COL3A1 and COL5A2, located on the long arm of human chromosome 2.","date":"1988","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/3224983","citation_count":26,"is_preprint":false},{"pmid":"11843319","id":"PMC_11843319","title":"Ehlers-Danlos syndrome type IV with few extrathoracic findings: a newly recognized point mutation in the COL3A1 gene.","date":"2002","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/11843319","citation_count":25,"is_preprint":false},{"pmid":"25330296","id":"PMC_25330296","title":"The Tsk2/+ mouse fibrotic phenotype is due to a gain-of-function mutation in the PIIINP segment of the Col3a1 gene.","date":"2014","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25330296","citation_count":24,"is_preprint":false},{"pmid":"12149201","id":"PMC_12149201","title":"Genetic variability in the extracellular matrix as a determinant of cardiovascular risk: association of type III collagen COL3A1 polymorphisms with coronary artery disease.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12149201","citation_count":24,"is_preprint":false},{"pmid":"35274048","id":"PMC_35274048","title":"Radiation increases COL1A1, COL3A1, and COL1A2 expression in breast cancer.","date":"2022","source":"Open medicine (Warsaw, Poland)","url":"https://pubmed.ncbi.nlm.nih.gov/35274048","citation_count":23,"is_preprint":false},{"pmid":"33930075","id":"PMC_33930075","title":"COL3A1 rs1800255 polymorphism is associated with pelvic organ prolapse susceptibility in Caucasian individuals: Evidence from a meta-analysis.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/33930075","citation_count":23,"is_preprint":false},{"pmid":"28742248","id":"PMC_28742248","title":"Biallelic COL3A1 mutations result in a clinical spectrum of specific structural brain anomalies and connective tissue abnormalities.","date":"2017","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/28742248","citation_count":22,"is_preprint":false},{"pmid":"33472700","id":"PMC_33472700","title":"Lnc-GULP1-2:1 affects granulosa cell proliferation by regulating COL3A1 expression and localization.","date":"2021","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/33472700","citation_count":21,"is_preprint":false},{"pmid":"35930601","id":"PMC_35930601","title":"Silencing of COL3A1 represses proliferation, migration, invasion, and immune escape of triple negative breast cancer cells via down-regulating PD-L1 expression.","date":"2022","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/35930601","citation_count":21,"is_preprint":false},{"pmid":"16583319","id":"PMC_16583319","title":"Extracellular matrix containing mutated fibrillin-1 (Fbn1) down regulates Col1a1, Col1a2, Col3a1, Col5a1, and Col5a2 mRNA levels in Tsk/+ and Tsk/Tsk embryonic fibroblasts.","date":"2006","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/16583319","citation_count":21,"is_preprint":false},{"pmid":"11566270","id":"PMC_11566270","title":"Genomic organization of the human COL3A1 and COL5A2 genes: COL5A2 has evolved differently than the other minor fibrillar collagen genes.","date":"2001","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11566270","citation_count":21,"is_preprint":false},{"pmid":"19152942","id":"PMC_19152942","title":"The relationship between COL3A1 exon 31 polymorphism and pelvic organ prolapse.","date":"2009","source":"The Journal of urology","url":"https://pubmed.ncbi.nlm.nih.gov/19152942","citation_count":21,"is_preprint":false},{"pmid":"28436683","id":"PMC_28436683","title":"Dexmedetomidine Protects PC12 Cells from Lidocaine-Induced Cytotoxicity Through Downregulation of COL3A1 Mediated by miR-let-7b.","date":"2017","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28436683","citation_count":20,"is_preprint":false},{"pmid":"1979060","id":"PMC_1979060","title":"Physical mapping by PFGE localizes the COL3A1 and COL5A2 genes to a 35-kb region on human chromosome 2.","date":"1990","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1979060","citation_count":20,"is_preprint":false},{"pmid":"10923041","id":"PMC_10923041","title":"Characterization of 11 new mutations in COL3A1 of individuals with Ehlers-Danlos syndrome type IV: preliminary comparison of RNase cleavage, EMC and DHPLC assays.","date":"2000","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10923041","citation_count":20,"is_preprint":false},{"pmid":"3011647","id":"PMC_3011647","title":"The pro alpha 2(V) collagen gene (COL5A2) maps to 2q14----2q32, syntenic to the pro alpha 1 (III) collagen locus (COL3A1).","date":"1986","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/3011647","citation_count":20,"is_preprint":false},{"pmid":"17576241","id":"PMC_17576241","title":"RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin fibroblasts.","date":"2007","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/17576241","citation_count":19,"is_preprint":false},{"pmid":"12694234","id":"PMC_12694234","title":"Ehlers-Danlos syndrome type IV: unusual congenital anomalies in a mother and son with a COL3A1 mutation and a normal collagen III protein profile.","date":"2003","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12694234","citation_count":19,"is_preprint":false},{"pmid":"33280513","id":"PMC_33280513","title":"Role of COL3A1 and POSTN on Pathologic Stages of Esophageal Cancer.","date":"2020","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/33280513","citation_count":18,"is_preprint":false},{"pmid":"30837697","id":"PMC_30837697","title":"Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers-Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility.","date":"2019","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30837697","citation_count":18,"is_preprint":false},{"pmid":"11168790","id":"PMC_11168790","title":"Ehlers-Danlos syndrome type IV with a unique point mutation in COL3A1 and familial phenotype of myocardial infarction without organic coronary stenosis.","date":"2001","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11168790","citation_count":17,"is_preprint":false},{"pmid":"8320698","id":"PMC_8320698","title":"A T+6 to C+6 mutation in the donor splice site of COL3A1 IVS7 causes exon skipping and results in Ehlers-Danlos syndrome type IV.","date":"1993","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8320698","citation_count":17,"is_preprint":false},{"pmid":"35587586","id":"PMC_35587586","title":"Atypical variants in COL1A1 and COL3A1 associated with classical and vascular Ehlers-Danlos syndrome overlap phenotypes: expanding the clinical phenotype based on additional case reports.","date":"2022","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/35587586","citation_count":16,"is_preprint":false},{"pmid":"10051163","id":"PMC_10051163","title":"Large kindred with Ehlers-Danlos syndrome type IV due to a point mutation (G571S) in the COL3A1 gene of type III procollagen: low risk of pregnancy complications and unexpected longevity in some affected relatives.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10051163","citation_count":16,"is_preprint":false},{"pmid":"24760181","id":"PMC_24760181","title":"Collagen type III alpha 1 polymorphism (rs1800255, COL3A1 2209 G>A) assessed with high-resolution melting analysis is not associated with pelvic organ prolapse in the Dutch population.","date":"2014","source":"International urogynecology journal","url":"https://pubmed.ncbi.nlm.nih.gov/24760181","citation_count":15,"is_preprint":false},{"pmid":"31041498","id":"PMC_31041498","title":"Polymorphism rs1800255 from COL3A1 gene and the risk for pelvic organ prolapse.","date":"2019","source":"International urogynecology journal","url":"https://pubmed.ncbi.nlm.nih.gov/31041498","citation_count":14,"is_preprint":false},{"pmid":"17498619","id":"PMC_17498619","title":"Developmental changes of Col3a1 mRNA expression in muscle and their association with intramuscular collagen in pigs.","date":"2007","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/17498619","citation_count":14,"is_preprint":false},{"pmid":"25893343","id":"PMC_25893343","title":"Dysregulated COL3A1 and RPL8, RPS16, and RPS23 in Disc Degeneration Revealed by Bioinformatics Methods.","date":"2015","source":"Spine","url":"https://pubmed.ncbi.nlm.nih.gov/25893343","citation_count":13,"is_preprint":false},{"pmid":"34318601","id":"PMC_34318601","title":"A novel mutation in COL3A1 associates to vascular Ehlers-Danlos syndrome with predominant musculoskeletal involvement.","date":"2021","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34318601","citation_count":13,"is_preprint":false},{"pmid":"8919863","id":"PMC_8919863","title":"A dimorphic Alu Sb-like insertion in COL3A1 is ethnic-specific.","date":"1996","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/8919863","citation_count":12,"is_preprint":false},{"pmid":"25940258","id":"PMC_25940258","title":"A 19-year-old man with relapsing bilateral pneumothorax, hemoptysis, and intrapulmonary cavitary lesions diagnosed with vascular Ehlers-Danlos syndrome and a novel missense mutation in COL3A1.","date":"2015","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/25940258","citation_count":12,"is_preprint":false},{"pmid":"1560789","id":"PMC_1560789","title":"A 15 base-pair AT-rich variable number tandem repeat in the type III procollagen gene (COL3A1) as an informative marker for 2q31-2q32.3.","date":"1992","source":"Matrix (Stuttgart, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/1560789","citation_count":12,"is_preprint":false},{"pmid":"35720634","id":"PMC_35720634","title":"Knockdown of lncRNA-NEAT1 expression inhibits hypoxia-induced scar fibroblast proliferation through regulation of the miR-488-3p/COL3A1 axis.","date":"2022","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35720634","citation_count":11,"is_preprint":false},{"pmid":"8020975","id":"PMC_8020975","title":"Linkage mapping of the gene for type III collagen (COL3A1) to human chromosome 2q using a VNTR polymorphism.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8020975","citation_count":11,"is_preprint":false},{"pmid":"31391389","id":"PMC_31391389","title":"Vascular Ehlers-Danlos Syndrome with a Novel Missense Mutation in COL3A1: A Man in His 50s with Aortic Dissection after Interventional Treatment for Hemothorax as the First Manifestation.","date":"2019","source":"Internal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/31391389","citation_count":11,"is_preprint":false},{"pmid":"38530094","id":"PMC_38530094","title":"Role and mechanism of COL3A1 in regulating the growth, metastasis, and drug sensitivity in cisplatin-resistant non-small cell lung cancer cells.","date":"2024","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/38530094","citation_count":10,"is_preprint":false},{"pmid":"35047627","id":"PMC_35047627","title":"COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing's Sarcoma.","date":"2021","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/35047627","citation_count":10,"is_preprint":false},{"pmid":"18389341","id":"PMC_18389341","title":"A novel COL3A1 gene mutation in patient with aortic dissected aneurysm and cervical artery dissections.","date":"2008","source":"Heart and vessels","url":"https://pubmed.ncbi.nlm.nih.gov/18389341","citation_count":10,"is_preprint":false},{"pmid":"28183226","id":"PMC_28183226","title":"A New COL3A1 Mutation in Ehlers-Danlos Syndrome Vascular Type With Different Phenotypes in the Same Family.","date":"2017","source":"Vascular and endovascular surgery","url":"https://pubmed.ncbi.nlm.nih.gov/28183226","citation_count":10,"is_preprint":false},{"pmid":"23489429","id":"PMC_23489429","title":"A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.","date":"2013","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23489429","citation_count":10,"is_preprint":false},{"pmid":"20720362","id":"PMC_20720362","title":"Ehlers-Danlos syndrome type IV, vascular type, which demonstrated a novel point mutation in the COL3A1 gene.","date":"2010","source":"Internal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/20720362","citation_count":10,"is_preprint":false},{"pmid":"8019562","id":"PMC_8019562","title":"Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.","date":"1994","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/8019562","citation_count":10,"is_preprint":false},{"pmid":"37187299","id":"PMC_37187299","title":"Patient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics.","date":"2023","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/37187299","citation_count":9,"is_preprint":false},{"pmid":"27799058","id":"PMC_27799058","title":"Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.","date":"2016","source":"Journal of medical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/27799058","citation_count":9,"is_preprint":false},{"pmid":"1757960","id":"PMC_1757960","title":"Ehlers-Danlos syndrome type IV: phenotypic consequences of a splicing mutation in one COL3A1 allele.","date":"1991","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1757960","citation_count":9,"is_preprint":false},{"pmid":"37831068","id":"PMC_37831068","title":"RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential.","date":"2024","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/37831068","citation_count":8,"is_preprint":false},{"pmid":"35543214","id":"PMC_35543214","title":"Nonsyndromic arteriopathy and aortopathy and vascular Ehlers-Danlos syndrome causing COL3A1 variants.","date":"2022","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/35543214","citation_count":8,"is_preprint":false},{"pmid":"39761856","id":"PMC_39761856","title":"Unveiling ADAMTS12: A key driver of bladder cancer progression via COL3A1-Mediated activation of the FAK/PI3K/AKT signaling pathway.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39761856","citation_count":8,"is_preprint":false},{"pmid":"40280907","id":"PMC_40280907","title":"The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos Syndrome.","date":"2025","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/40280907","citation_count":8,"is_preprint":false},{"pmid":"27476968","id":"PMC_27476968","title":"miRNA-29a targets COL3A1 to regulate the level of type III collagen in pig.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/27476968","citation_count":8,"is_preprint":false},{"pmid":"25846194","id":"PMC_25846194","title":"Clinical, structural, biochemical and X-ray crystallographic correlates of pathogenicity for variants in the C-propeptide region of the COL3A1 gene.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25846194","citation_count":8,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48678,"output_tokens":5450,"usd":0.113892,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14091,"output_tokens":4868,"usd":0.096077,"stage2_stop_reason":"end_turn"},"total_usd":0.209969,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"A multi-exon deletion in one COL3A1 allele (3.3 kb deletion in the triple-helical coding domain) produces type III procollagen with decreased thermal stability, reduced secretion efficiency, and impaired processing, establishing that structural integrity of the triple helix is required for normal folding, secretion, and protease processing of type III collagen.\",\n      \"method\": \"Fibroblast culture biochemical analysis, mRNA/protein analysis, thermal stability assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical characterization with multiple orthogonal methods (thermal stability, secretion assay, protein analysis) in a focused single-gene study; foundational characterization\",\n      \"pmids\": [\"2834369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"A glycine-to-arginine substitution (G619R) in the triple-helical domain of COL3A1 decreases the thermal unfolding temperature of type III procollagen in cultured skin fibroblasts, demonstrating that glycine substitutions in the triple helix destabilize the collagen molecule and cause familial aortic aneurysms.\",\n      \"method\": \"Cultured skin fibroblast analysis, thermal unfolding assay, DNA sequencing\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical measurement (thermal stability) of mutant protein from patient fibroblasts, replicated across multiple family members\",\n      \"pmids\": [\"2243125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Identical G+1 splice-site mutations in three different introns of COL3A1 produce distinct patterns of aberrant RNA splicing (exon skipping, cryptic splice site use, or intron retention), demonstrating that context of adjacent introns—not the mutation per se—determines the splicing outcome.\",\n      \"method\": \"RNA analysis, cDNA sequencing, splice-site analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct comparative molecular analysis of three independent mutations in the same gene with orthogonal RNA/DNA methods\",\n      \"pmids\": [\"2365710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"A splice-site mutation (G+1 IVS20 → A) in COL3A1 causes aberrant RNA splicing producing structurally abnormal type III procollagen; the resulting protein has impaired secretion and function, leading to vascular rupture phenotype.\",\n      \"method\": \"RNA splicing analysis, fibroblast protein studies, DNA sequencing\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — molecular characterization with RNA and protein analysis in patient fibroblasts, single lab\",\n      \"pmids\": [\"2349939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"A splice-site mutation (G-to-A at the GT dinucleotide of intron 41 donor site) in COL3A1 causes exon 41 skipping, producing a type III procollagen molecule lacking the collagenase cleavage site (Gly781-Ile782) and the cyanogen bromide site (Met797), making it resistant to both collagenase and CNBr digestion; secretion is markedly reduced and thermal stability is decreased.\",\n      \"method\": \"cDNA sequencing, CNBr peptide mapping, chemical cleavage heteroduplex analysis, protein secretion assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods (CNBr mapping, collagenase resistance, secretion assay, sequencing) in a single rigorous study establishing mechanism\",\n      \"pmids\": [\"2145268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Glycine-to-aspartate substitution at position 1018 in the COL3A1 triple helix markedly decreases secretion of type III procollagen by cultured fibroblasts, demonstrating that glycine substitutions near the C-terminus of the helix strongly impair secretion.\",\n      \"method\": \"Cultured skin fibroblast protein analysis, PCR/sequencing, quantification of secreted collagen\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct measurement of secreted protein from patient fibroblasts, single lab\",\n      \"pmids\": [\"1496983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Glycine-to-glutamic-acid substitution at position 1021 (the most C-terminal glycine mutation characterized at the time) in COL3A1 causes poor secretion of type III procollagen, slower electrophoretic migration (indicating overmodification), and partial instability to trypsin digestion at 25°C, linking C-terminal helix mutations to specific biochemical defects.\",\n      \"method\": \"Fibroblast protein analysis, SDS-PAGE, trypsin sensitivity assay\",\n      \"journal\": \"American journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical assays on patient fibroblasts, single lab\",\n      \"pmids\": [\"8098182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Mutations in COL3A1 (point mutations substituting glycine residues near the C-terminus, and exon-skipping mutations) cause ultrastructurally abnormal collagen fibrils in dermis (reduced fibril diameter to 65–80 nm vs. 95–110 nm in normal), dilated rough endoplasmic reticulum, and reduced dermal collagen content; severity of structural changes correlates with position and nature of the mutation.\",\n      \"method\": \"Light microscopy, transmission and scanning electron microscopy of skin biopsies from 22 genotyped EDS IV patients\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic ultrastructural analysis across 22 patients with defined mutations, multiple orthogonal microscopy methods\",\n      \"pmids\": [\"9036918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Frameshift and nonsense mutations in COL3A1 leading to premature termination codons cause nonsense-mediated mRNA decay (NMD), resulting in haploinsufficiency for type III procollagen rather than production of structurally abnormal protein; a C-terminal truncation mutation (Arg1432Ter) in the final exon escapes NMD but produces a truncated protein not incorporated into mature type III procollagen trimers.\",\n      \"method\": \"RT-PCR, mRNA stability assay, protein analysis of fibroblast culture media\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic dissection of NMD pathway using multiple patient mutations and orthogonal RNA/protein methods\",\n      \"pmids\": [\"11577371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Fibroblasts from EDS IV patients with COL3A1 mutations fail to organize type III collagen and fibronectin into extracellular matrix, downregulate α2β1 integrin, and recruit αvβ3 instead of α5β1 integrin; treatment with exogenous purified type III collagen restores normal integrin distribution and ECM organization, demonstrating that type III collagen controls α2β1 integrin function which in turn regulates fibronectin receptor recruitment.\",\n      \"method\": \"Immunofluorescence, western blot, treatment with purified collagen and function-blocking antibodies, ECM organization assays in patient fibroblasts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal experiments including rescue with purified protein and function-blocking antibodies establishing mechanistic link between COL3A1 and integrin regulation\",\n      \"pmids\": [\"14970208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Loss of Col3a1 in mice causes breakdown of the pial basement membrane starting at E11.5 with consequent neuronal overmigration, cobblestone-like cortical malformation, and marginal zone heterotopias, establishing type III collagen as a structural ligand required for pial basement membrane integrity during cortical development; α-dystroglycan expression and modification were unaffected in Col3a1-null meningeal fibroblasts.\",\n      \"method\": \"Histological analysis, immunofluorescence, Col3a1 knockout mouse model, time-course developmental analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with defined cellular phenotype, time-course analysis, negative control (α-dystroglycan) included\",\n      \"pmids\": [\"22235340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A missense point mutation in the PIIINP (N-terminal propeptide) segment of Col3a1 is the causative gain-of-function mutation in Tsk2/+ mice; this mutation drives excessive ECM deposition and skin fibrosis, establishing that the N-terminal propeptide domain can confer a fibrotic gain-of-function phenotype distinct from the loss-of-function EDS IV mutations.\",\n      \"method\": \"Linkage analysis, RNA sequencing, genome capture DNA sequencing, in vivo and in vitro genetic complementation tests\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic complementation in vivo and in vitro with multiple molecular methods proving causality of the specific mutation\",\n      \"pmids\": [\"25330296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Biallelic (homozygous or compound heterozygous) mutations in COL3A1 are associated with cobblestone-like cortical malformation, white matter changes, and cerebellar cysts similar to the phenotype of GPR56 mutations, establishing that the type III collagen–GPR56 ligand–receptor axis is required for cortical lamination and brain development.\",\n      \"method\": \"Exome sequencing, functional assays on dermal fibroblasts, MRI brain imaging in multiple families\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and functional fibroblast data across three families, consistent phenotype linking COL3A1 to GPR56 signaling axis\",\n      \"pmids\": [\"28258187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NEDD9, a SMAD3 docking partner, forms a complex with NKX2-5 transcription factor when SMAD3-NEDD9 interaction is impaired by oxidation of Cys18 (induced by aldosterone); increased NEDD9-NKX2-5 complex binds to the COL3A1 promoter and drives collagen III expression in pulmonary artery endothelial cells, promoting vascular fibrosis in pulmonary arterial hypertension via a TGF-β-independent mechanism.\",\n      \"method\": \"Microscale thermophoresis (protein-protein interaction), atomic force microscopy (cell stiffness), ChIP (NKX2-5 binding to COL3A1), cell culture, animal models of PAH, immunohistochemistry co-localization\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods including direct binding assay, ChIP, functional rescue, and in vivo validation establishing upstream regulatory mechanism of COL3A1 expression\",\n      \"pmids\": [\"29899023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Transgenic mice expressing a glycine substitution mutation (p.Gly182Ser) in Col3a1 develop reduced total collagen content, an abnormal collagen III:I ratio, and severely malformed collagen fibrils in dermal and arterial ECM, demonstrating that mutant type III collagen disrupts heterotypic type III:I collagen fibrillogenesis in vivo.\",\n      \"method\": \"Transgenic mouse model, collagen content assay, electron microscopy of collagen fibrils, ratio analysis\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic mouse with defined glycine substitution, ultrastructural and biochemical analysis of collagen fibrils providing mechanistic link between mutation and fibrillogenesis defect\",\n      \"pmids\": [\"29551664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Dominant-negative COL3A1 mutations in patient fibroblasts cause aberrant type III collagen (COLLIII) expression that leads to disassembly of ECM structural components (fibrillins, EMILINs, elastin) and reduction of proteoglycans (perlecan, decorin, versican), disruption of ER homeostasis markers (PDI distribution, reduction of FKBP22), and altered cell cycle regulation, as revealed by transcriptome and protein analyses.\",\n      \"method\": \"Microarray transcriptome analysis, protein analysis (western blot, immunofluorescence), cultured patient fibroblasts\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transcriptome plus protein validation in patient fibroblasts with defined mutations, single lab\",\n      \"pmids\": [\"29346445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ECM generated from vEDS patient fibroblasts with COL3A1 mutations (including a glycine substitution) shows altered protein composition (upregulation of collagen subtypes and structural proteins), increased glycosaminoglycan content, and unique viscoelastic mechanical properties (increased stress relaxation time constant) compared to healthy donor ECM; this mechanically altered ECM reduces migration speed of seeded human aortic endothelial cells.\",\n      \"method\": \"Cell-derived ECM synthesis from primary patient fibroblasts, mass spectrometry protein content analysis, glycosaminoglycan quantification, atomic force microscopy and rheology for viscoelastic properties, endothelial cell migration assay\",\n      \"journal\": \"Acta biomaterialia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — reconstitution of patient-derived ECM with multiple orthogonal biochemical and biophysical methods plus functional cell assay; single lab\",\n      \"pmids\": [\"37187299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"COL3A1 glycine mutations (G189S and G906R) in patient fibroblasts cause secretion of misfolded collagen III, intracellular collagen retention, ER stress via IRE1 and PERK pathway activation, reduced cell proliferation, and apoptosis; treatment with 4-phenylbutyric acid (PBA) rescues ER stress, improves thermal stability of secreted collagen, reduces apoptosis, and corrects matrix defects, with efficacy influenced by mutation position and allelic heterogeneity.\",\n      \"method\": \"Primary patient fibroblast cultures, ER stress pathway analysis (IRE1/PERK), thermal stability assay, collagen secretion assay, proliferation assay, apoptosis assay, pharmacological rescue with PBA\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal mechanistic assays in patient-derived cells with pharmacological rescue experiment confirming ER stress as operative mechanism; single lab\",\n      \"pmids\": [\"40280907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ELAVL1 (HuR) enhances mRNA stability and expression of COL3A1, while YY1 promotes COL3A1 transcription; both mechanisms contribute to COL3A1 upregulation in cisplatin-resistant NSCLC cells, and COL3A1 knockdown reverses ELAVL1- or YY1-depletion-mediated resistance phenotypes.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, qPCR, western blot, mRNA stability assay, loss-of-function experiments\",\n      \"journal\": \"Cancer biology & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase confirming direct YY1-COL3A1 transcriptional regulation and ELAVL1 mRNA stabilization; single lab, cancer cell context\",\n      \"pmids\": [\"38530094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"C-propeptide region variants in COL3A1 (exons 49–52) affect the initiation of C-terminal assembly of procollagen monomers in collagen biosynthesis; X-ray crystallographic structural data combined with clinical phenotyping inform pathogenicity classification of missense variants in this domain.\",\n      \"method\": \"X-ray crystallography of C-propeptide region variants, clinical phenotyping, biochemical analysis\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structure data mentioned but abstract provides limited mechanistic detail on experimental outcomes; single study\",\n      \"pmids\": [\"25846194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Haploinsufficiency of Col3a1 (heterozygous 185 kb deletion including promoter and exons 1–39) causes autosomal-dominant susceptibility to thoracic aortic dissection in mice with aberrant collagen fibrillogenesis in the aortic wall, without elevated blood pressure or aneurysm formation.\",\n      \"method\": \"Spontaneous mouse mutant identification, molecular genetic analysis, echocardiography, histological analysis\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — defined deletion allele with molecular characterization plus histological and functional cardiovascular phenotyping in vivo\",\n      \"pmids\": [\"21071432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Angiotensin II infusion in Col3a1 haploinsufficient mice selectively promotes thoracic aortic dissections and ruptures associated with low aortic collagen fibril content, demonstrating that reduced type III collagen renders the aortic wall mechanically vulnerable to hemodynamic stress; the same blood pressure increase produced by norepinephrine does not cause comparable mortality, implicating angiotensin II-specific effects beyond blood pressure.\",\n      \"method\": \"Angiotensin II infusion model in Col3a1+/- mice, echocardiography, histological analysis, mortality comparison\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo pharmacological model with defined genetic background and histological endpoint, single lab\",\n      \"pmids\": [\"23630948\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"COL3A1 encodes the pro-α1(III) chain that homotrimerizes to form type III procollagen; glycine substitutions or splice mutations in the triple-helical domain reduce thermal stability, impair secretion, cause ER stress via IRE1/PERK activation, and disrupt heterotypic type I/III collagen fibrillogenesis, while haploinsufficiency reduces ECM collagen content and mechanical integrity of arterial and connective tissue walls; at the cell-biology level, type III collagen acts as an ECM ligand controlling α2β1 integrin function and downstream fibronectin/integrin receptor recruitment, and as the ligand for GPR56 required for pial basement membrane integrity and cortical lamination during brain development; transcriptional regulation involves YY1-driven promoter activity and ELAVL1-mediated mRNA stabilization, and aldosterone-induced oxidation of NEDD9 releases NKX2-5 to drive COL3A1 expression in a TGF-β-independent pathway relevant to pulmonary vascular fibrosis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"COL3A1 encodes the pro-α1(III) chain whose homotrimer forms type III procollagen, an extracellular matrix structural protein essential for the mechanical integrity of arterial and connective tissue walls and for tissue patterning during development [#0, #14, #20]. The structural integrity of the Gly-X-Y triple-helical domain is required for normal folding, secretion, and protease processing: triple-helix deletions and glycine substitutions lower thermal stability and impair secretion [#0, #1, #5], while C-terminal helix mutations and exon-skipping events further compromise secretion and remove protease/CNBr cleavage sites [#4, #6]. Splice-site mutations generate context-dependent aberrant transcripts (exon skipping, cryptic site use, intron retention) yielding abnormal procollagen [#2, #4], whereas frameshift and nonsense mutations trigger nonsense-mediated decay and consequent haploinsufficiency [#8]. Misfolded mutant chains are retained intracellularly and activate ER stress through the IRE1 and PERK arms, driving reduced proliferation and apoptosis that are reversible by chemical chaperone treatment with 4-phenylbutyric acid [#17]. At the tissue level, mutant or reduced type III collagen disrupts heterotypic type III:I collagen fibrillogenesis, lowering collagen content and altering fibril architecture in dermis and aorta [#7, #14], and haploinsufficiency confers susceptibility to thoracic aortic dissection that is exacerbated by angiotensin II-driven hemodynamic stress [#20, #21]. Beyond its structural role, type III collagen functions as an ECM ligand: it controls α2β1 integrin function and downstream fibronectin/integrin receptor recruitment [#9], and serves as the ligand for GPR56 required for pial basement membrane integrity and cortical lamination, with biallelic loss causing cobblestone-like cortical malformation [#10, #12]. COL3A1 expression is controlled transcriptionally by YY1 and post-transcriptionally by ELAVL1-mediated mRNA stabilization [#18], and by an aldosterone-induced NEDD9–NKX2-5 pathway that drives collagen III expression in pulmonary artery endothelial cells independently of TGF-β [#13]. Dominant glycine and splice mutations underlie vascular Ehlers-Danlos syndrome (EDS IV) and familial aortic aneurysm/dissection [#1, #7].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Established that triple-helix structural integrity is a prerequisite for normal folding, secretion, and processing of type III procollagen, defining the molecular logic of dominant COL3A1 disease.\",\n      \"evidence\": \"Biochemical analysis of a triple-helical domain deletion in patient fibroblasts with thermal stability and secretion assays\",\n      \"pmids\": [\"2834369\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address how reduced thermal stability translates to tissue-level fragility\", \"Single deletion allele tested\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Showed that point glycine substitutions in the triple helix destabilize the collagen molecule and cause familial aortic aneurysm, and that splice-site mutations produce context-dependent aberrant transcripts.\",\n      \"evidence\": \"Thermal unfolding assays on fibroblast-derived mutant procollagen and comparative RNA/cDNA analysis of multiple splice mutations\",\n      \"pmids\": [\"2243125\", \"2365710\", \"2349939\", \"2145268\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish in vivo tissue consequences\", \"Splicing outcome rules predictive only for the introns tested\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Localized secretion sensitivity to the C-terminal region of the helix, showing C-terminal glycine substitutions strongly impair procollagen secretion.\",\n      \"evidence\": \"Secreted collagen quantification, SDS-PAGE migration and trypsin sensitivity assays in patient fibroblasts\",\n      \"pmids\": [\"1496983\", \"8098182\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Mechanistic basis of position-dependent secretion defect not resolved\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Connected molecular mutation type to ultrastructural matrix pathology, showing reduced fibril diameter, dilated rough ER, and lower dermal collagen content correlating with mutation position.\",\n      \"evidence\": \"Light, transmission and scanning electron microscopy of skin biopsies from 22 genotyped EDS IV patients\",\n      \"pmids\": [\"9036918\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Correlation descriptive, not causal\", \"Did not define the signaling consequence of dilated ER\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Distinguished haploinsufficiency from dominant-negative mechanisms by showing premature termination codons trigger NMD while a final-exon truncation escapes decay but fails to incorporate into trimers.\",\n      \"evidence\": \"RT-PCR, mRNA stability assays and protein analysis of patient fibroblast media\",\n      \"pmids\": [\"11577371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not quantify phenotypic difference between haploinsufficient and dominant-negative patients\", \"Limited mutation set\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Revealed a non-structural signaling role: type III collagen controls α2β1 integrin function and fibronectin receptor recruitment, with rescue by exogenous collagen establishing causality.\",\n      \"evidence\": \"Immunofluorescence, western blot, function-blocking antibodies and purified-collagen rescue in EDS IV patient fibroblasts\",\n      \"pmids\": [\"14970208\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream integrin signaling cascade not mapped\", \"Relevance to in vivo vascular phenotype not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated that Col3a1 haploinsufficiency alone causes autosomal-dominant susceptibility to thoracic aortic dissection via aberrant aortic fibrillogenesis, independent of blood pressure or aneurysm.\",\n      \"evidence\": \"Spontaneous mouse deletion mutant with molecular genetics, echocardiography and histology\",\n      \"pmids\": [\"21071432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the hemodynamic trigger of dissection\", \"Mechanism of selective thoracic vulnerability unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified type III collagen as a structural ligand required for pial basement membrane integrity, with loss causing neuronal overmigration and cobblestone cortical malformation.\",\n      \"evidence\": \"Col3a1 knockout mouse with time-course histology and immunofluorescence, including α-dystroglycan negative control\",\n      \"pmids\": [\"22235340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor mediating the developmental requirement not identified in this study\", \"Did not test rescue\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed angiotensin II selectively precipitates aortic dissection in haploinsufficient mice beyond its blood-pressure effect, implicating an angiotensin II-specific vulnerability of collagen-poor walls.\",\n      \"evidence\": \"Angiotensin II versus norepinephrine infusion in Col3a1+/- mice with echocardiography, histology and mortality comparison\",\n      \"pmids\": [\"23630948\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Angiotensin II-specific molecular pathway not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established that the N-terminal propeptide domain can confer a fibrotic gain-of-function, mechanistically distinct from loss-of-function EDS IV mutations.\",\n      \"evidence\": \"Linkage, RNA-seq, genome capture sequencing and in vivo/in vitro genetic complementation in Tsk2/+ mice\",\n      \"pmids\": [\"25330296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular pathway driving excess ECM deposition not defined\", \"Mouse-specific; human relevance untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined a role for the C-propeptide in initiating C-terminal assembly of procollagen monomers and used structural data to inform variant pathogenicity.\",\n      \"evidence\": \"X-ray crystallography of C-propeptide variants combined with clinical phenotyping\",\n      \"pmids\": [\"25846194\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Limited mechanistic outcome detail reported\", \"Single study\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Linked biallelic COL3A1 loss to a GPR56-like cortical phenotype, establishing the type III collagen–GPR56 ligand–receptor axis in cortical lamination.\",\n      \"evidence\": \"Exome sequencing, fibroblast functional assays and brain MRI across multiple families\",\n      \"pmids\": [\"28258187\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct collagen III–GPR56 binding not demonstrated here\", \"Three families only\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined upstream and downstream consequences of COL3A1 dysregulation: an aldosterone-driven NEDD9–NKX2-5 pathway drives COL3A1 transcription in pulmonary fibrosis, mutant collagen disrupts heterotypic III:I fibrillogenesis in vivo, and dominant-negative mutations perturb ECM assembly and ER homeostasis.\",\n      \"evidence\": \"Microscale thermophoresis, ChIP and PAH models; transgenic glycine-substitution mouse with EM; transcriptome plus protein analysis of patient fibroblasts\",\n      \"pmids\": [\"29899023\", \"29551664\", \"29346445\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"NEDD9-NKX2-5 pathway shown in PAH context only\", \"ECM disassembly findings from a single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed that vEDS patient-derived matrix has altered composition and viscoelastic properties that impair endothelial cell migration, linking the mutation to mechanical and functional ECM defects.\",\n      \"evidence\": \"Cell-derived ECM, mass spectrometry, GAG quantification, AFM/rheology and endothelial migration assay\",\n      \"pmids\": [\"37187299\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single lab\", \"In vitro ECM may not reflect arterial wall mechanics\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified transcriptional (YY1) and post-transcriptional (ELAVL1) regulators of COL3A1 and implicated COL3A1 in cisplatin resistance in NSCLC.\",\n      \"evidence\": \"ChIP, luciferase reporter, mRNA stability and loss-of-function assays in NSCLC cells\",\n      \"pmids\": [\"38530094\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cancer-cell context; relevance to connective tissue regulation unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established ER stress via IRE1/PERK as an operative pathomechanism of glycine mutations and demonstrated pharmacological rescue with the chemical chaperone 4-phenylbutyric acid.\",\n      \"evidence\": \"ER stress pathway, thermal stability, secretion, proliferation and apoptosis assays with PBA rescue in patient fibroblasts\",\n      \"pmids\": [\"40280907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Rescue efficacy mutation-position dependent\", \"In vivo therapeutic validation absent\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the structural, integrin-signaling, GPR56-developmental, and ER-stress functions of type III collagen are integrated to produce tissue-specific disease, and whether ER-stress or transcriptional modulation can be therapeutically exploited in vivo, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo therapeutic proof for PBA or pathway modulation\", \"Mechanistic link between matrix mechanics and clinical vascular events incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 14, 20]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [9, 10, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [9, 14, 16]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7, 17]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [9, 14, 16]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [17]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ITGA2\", \"GPR56\", \"FN1\", \"NKX2-5\", \"NEDD9\", \"YY1\", \"ELAVL1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}